Tilray Brands (NASDAQ:TLRY) Trading Up 3.9% – Should You Buy?

Tilray Brands, Inc. (NASDAQ:TLRY)’s stock price rose 3.9% on Monday . The company traded as high as $4.08 and last traded at $4.03. 3,577,522 shares changed hands during mid-day trading, a decline of 15% from the average session volume of 4,208,949 shares. The stock had previously closed at $3.88.

Tilray Brands News Roundup

Here are the key news stories impacting Tilray Brands this week:

• Positive Sentiment: Fiscal 2026 net revenue reached a record $915 million, while adjusted EBITDA also set a record. Management forecast fiscal 2027 adjusted EBITDA of $68 million to $75 million, representing expected double-digit growth and potential margin expansion. Tilray Brands fiscal 2026 results
• Positive Sentiment: Fourth-quarter revenue rose 25.5% year over year to $281.7 million, exceeding analyst estimates, and gross profit increased 33.8% to $90.5 million. International medical cannabis revenue grew 34% for the full year, while the BrewDog acquisition expanded Tilray’s beverage and hospitality platform. Tilray fourth-quarter financial data
• Positive Sentiment: Tilray reported approximately $235 million in cash, restricted cash and marketable securities and reduced net debt to roughly $0.7 million, supporting its balance-sheet position. Tilray balance sheet and outlook

Wall Street Analyst Weigh In

A number of equities analysts have commented on TLRY shares. ATB Cormark Capital Markets cut their price objective on shares of Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research report on Thursday, April 2nd. Roth Capital raised shares of Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 target price on the stock in a report on Thursday, April 2nd. Weiss Ratings lowered shares of Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. Finally, TD Cowen cut their price target on shares of Tilray Brands from $7.00 to $5.00 and set a “buy” rating for the company in a report on Tuesday, July 14th. Three research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $11.00.

Tilray Brands Stock Performance

The stock has a 50 day moving average of $4.74 and a two-hundred day moving average of $6.34. The stock has a market capitalization of $464.45 million, a PE ratio of -0.29 and a beta of 1.89. The company has a debt-to-equity ratio of 0.19, a current ratio of 2.79 and a quick ratio of 1.66.

Tilray Brands (NASDAQ:TLRY) last released its quarterly earnings data on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.42). The business had revenue of $281.71 million during the quarter, compared to analysts’ expectations of $246.30 million. Tilray Brands had a negative return on equity of 3.31% and a negative net margin of 156.51%. Research analysts expect that Tilray Brands, Inc. will post -0.58 EPS for the current fiscal year.

Hedge Funds Weigh In On Tilray Brands

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Hilton Head Capital Partners LLC acquired a new stake in shares of Tilray Brands in the fourth quarter valued at about $38,000. Cerity Partners LLC grew its position in Tilray Brands by 98.5% during the second quarter. Cerity Partners LLC now owns 92,560 shares of the company’s stock worth $38,000 after buying an additional 45,929 shares during the period. Marex Group plc purchased a new position in Tilray Brands in the second quarter valued at about $40,000. Hilton Capital Management LLC purchased a new position in Tilray Brands in the second quarter valued at about $41,000. Finally, Essential Partners LLC lifted its position in shares of Tilray Brands by 110,137.5% during the 1st quarter. Essential Partners LLC now owns 8,819 shares of the company’s stock valued at $57,000 after acquiring an additional 8,811 shares during the period. 9.35% of the stock is owned by institutional investors and hedge funds.

About Tilray Brands

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.